~~<i id='2DFD7CDA32'><strike id='2DFD7CDA32'><tt id='2DFD7CDA32'><pre id='2DFD7CDA32'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：entertainment 2025-10-03 00:03:46 - browse：796

A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of major adverse cardiac and cerebrovascular events and even cardiac death rates, according to a new study published Tuesday in the Journal of the American Medical Association.

However, some outside experts expressed skepticism about the result.

Tongxinluo — which means “to open (tong) the network (luo) of the heart (xin)” in Mandarin — is a traditional Chinese medicine compound made out of a mixture of powders and extracts from plants, centipedes, cicadas, and other sources.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Life science postdocs should get big pay hike, NIH panel says

entertainment

explore

leisure time

entertainment

focus

EricTokatisco-presidentofinvestmentbankingatCenterviewPartners.CourtesyCenterviewPartnersSANFRANCISC

WSS

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Gene therapy denied for Afghan refugee whose father aided U.S.

SNAP should offer more nutrition education

Editas, Vertex strike deal on CRISPR

Profiling embryos to choose those with higher IQs is almost a reality

Ascension's ugly legal battle over care for poor patients in Texas

leisure time

hotspot

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

In shift, Texas to cover initial consult for Afghan baby's gene therapy

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Editas, Vertex strike deal on CRISPR

How to save PrEP access — and even expand it

Arena BioWorks launches in Cambridge to speed drug discovery

What does generative AI mean for health care? We asked experts

At JPM 2024, hospital systems pitch financial strength to investors

BioMarin wins approval for gene therapy to treat hemophilia A

Fauci's latest grilling in Congress: 9 hours, behind closed doors

explore

SNAP should offer more nutrition education

Medicare Advantage coverage denials need scrutiny, senators say

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Medicare Advantage coverage denials need scrutiny, senators say

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Ascension's ugly legal battle over care for poor patients in Texas

leisure time

leisure time

entertainment

focus